NQO1 substrate
CAS No. 2304503-05-5
NQO1 substrate( —— )
Catalog No. M33225 CAS No. 2304503-05-5
NQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 58 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNQO1 substrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.
-
DescriptionNQO1 substrate acts as an efficient NQO1 substrate and may be a new option for the treatment of NQO1-overexpresssing drug-resistant NSCLC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNADPH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2304503-05-5
-
Formula Weight268.18
-
Molecular FormulaC13H2F2N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (466.10 mM; Ultrasonic )
-
SMILESFc1cc2C(=O)c3nc(C#N)c(nc3-c2cc1F)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
APX-115
APX-115 (Ewha 18278)?is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.
-
Dicumarol
An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
-
5-Heneicosylresorcin...
5-Heneicosylresorcinol shows inhibitory effects on the release of β-hexosaminidase from RBL-2H3 cells, it also prevents triglyceride accumulation in 3T3-L1 cells. 5-Heneicosylresorcinol has nematicidal activity against nematodes Panagrellus redivivus, Caenothabditis elegans and Bursaphelenchus xylophilus, with ED50 values of 80, 30, and 180 ug/mL, respectively.
Cart
sales@molnova.com